Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:49-55, doi:10.1016/j.jacc.2007.07.086
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by deGoma, E. M.
Right arrow Articles by Heidenreich, P. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by deGoma, E. M.
Right arrow Articles by Heidenreich, P. A.
Related Collections
Right arrowRelated Articles

Clinical Significance of High-Density Lipoprotein Cholesterol in Patients With Low Low-Density Lipoprotein Cholesterol

Emil M. deGoma, MD*,*, Nicholas J. Leeper, MD* and Paul A. Heidenreich, MD, MS*,{dagger}

* Department of Cardiology, Stanford University Hospital, Stanford, California
{dagger} Department of Cardiology, Veterans Administration Palo Alto Health Care System, Palo Alto, California.


Figure 1
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Unadjusted Rates of the Combined Primary End Point

Unadjusted rates of myocardial injury or ischemic heart disease (IHD) hospitalization (n = 3,982) and the secondary end point, all-cause mortality (n = 4,188), at 1 year after the index low-density lipoprotein cholesterol date are shown. In univariate analysis, an inverse relationship was shown between high-density lipoprotein cholesterol (HDL-C) and admission for IHD, whereas a U-shaped relationship was observed between HDL-C and the risk of overall mortality at 1 year. p = 0.001 for myocardial injury or IHD hospitalization; p = 0.01 for total mortality. Q1 to Q4 = HDL-C quartiles 1 to 4.

 

Figure 2
View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Adjusted Odds Ratios for the Combined Primary End Point

Adjusted odds ratios of myocardial injury or ischemic heart disease (IHD) admission (n = 3,884) and the secondary end point, death from any cause (n = 4,070), at 1 year after the index low-density lipoprotein cholesterol date are shown. In multivariate-adjusted analysis using the highest high-density lipoprotein cholesterol (HDL-C) quartile (Q4) as the reference quartile, an inverse relationship was shown between HDL-C and admission for IHD, whereas a U-shaped relationship was observed between HDL-C and the risk of overall mortality at 1 year. The p values for myocardial injury or IHD admission: 0.04 HDL-C categoric, 0.007 HDL-C continuous. The p values for total mortality: 0.18 HDL-C categoric, 0.001 for separate linear relationships above and below HDL-C of 43 mg/dl.

 

Figure 3
View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Risk Ratios for Death From Any Cause

In multivariable analysis adjusted for demographics, medical history, laboratory values, and medication use, analysis of the odds ratios for death from any cause using the highest high-density lipoprotein cholesterol (HDL-C) quartile (Q4) as the reference quartile revealed a U-shaped curve, with the highest risk of mortality observed in the lowest and highest quartiles, similar to findings observed in earlier epidemiologic studies. *Adjusted for age, diastolic blood pressure, and cigarettes/day. {dagger}Not adjusted. {ddagger}Adjusted for age, mean daily alcohol consumption, body mass index, education, physical activity, cigarettes/day, systolic blood pressure, and total cholesterol. §Adjusted for age. ||Adjusted for age, gender, ischemic heart disease, stroke, peripheral arterial disease, congestive heart failure, diabetes, hypertension, malignancy, chronic obstructive pulmonary disease, liver disease, alcohol dependence or abuse, statin use, fibrate use, creatinine, hemoglobin A1c, troponin, hemoglobin, low-density lipoprotein cholesterol, aspartate aminotransferase, and triglycerides. PAVA = Palo Alto Veterans Administration (present study). Q1 to Q4 = HDL-C quartiles 1 to 4; Q1 to Q5 = HDL-C quintiles 1 to 5; S1 to S6 = HDL-C sextiles 1 to 6; T1 to T3 = HDL-C tertiles 1 to 3.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement